Your browser doesn't support javascript.
loading
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2.
Fiaschi, Lia; Dragoni, Filippo; Schiaroli, Elisabetta; Bergna, Annalisa; Rossetti, Barbara; Giammarino, Federica; Biba, Camilla; Gidari, Anna; Lai, Alessia; Nencioni, Cesira; Francisci, Daniela; Zazzi, Maurizio; Vicenti, Ilaria.
Affiliation
  • Fiaschi L; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
  • Dragoni F; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
  • Schiaroli E; Department of Medicine and Surgery, Clinic of Infectious Diseases, University of Perugia, 06129 Perugia, Italy.
  • Bergna A; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, 20157 Milan, Italy.
  • Rossetti B; Infectious Disease Department, USL SUDEST, Toscana, Misericordia Hospital, 58100 Grosseto, Italy.
  • Giammarino F; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
  • Biba C; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
  • Gidari A; Department of Medicine and Surgery, Clinic of Infectious Diseases, University of Perugia, 06129 Perugia, Italy.
  • Lai A; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, 20157 Milan, Italy.
  • Nencioni C; Infectious Disease Department, USL SUDEST, Toscana, Misericordia Hospital, 58100 Grosseto, Italy.
  • Francisci D; Department of Medicine and Surgery, Clinic of Infectious Diseases, University of Perugia, 06129 Perugia, Italy.
  • Zazzi M; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
  • Vicenti I; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Viruses ; 14(7)2022 06 23.
Article in En | MEDLINE | ID: mdl-35891355

Full text: 1 Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Limits: Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Limits: Humans Language: En Year: 2022 Type: Article